# Evaluate Analgesic Efficacy of Fast Release Aspirin

> **NCT01122602** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 500 (actual)

## Conditions studied

- Drugs, Investigational

## Interventions

- **DRUG:** Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)
- **DRUG:** Acetylsalicyclic acid (Aspirin, BAYE4465)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01122602
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-29
- **Primary completion:** 2010-07-29
- **Final completion:** 2010-08-06
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01122602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01122602, "Evaluate Analgesic Efficacy of Fast Release Aspirin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01122602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*